期刊文献+

硫酸氨基葡萄糖联合非甾体抗炎药治疗中度骨关节炎的研究 被引量:11

下载PDF
导出
摘要 目的研究硫酸氨基葡萄糖联合非甾体抗炎药治疗中度膝关节骨关节炎的疗效。方法抽取368例患有中度膝关节骨性关节炎的门诊患者,随机分为单独采用硫酸氨基葡萄糖治疗(A组)与采用硫酸氨基葡萄糖联合非甾体抗炎药(NSAIDs)治疗(B组),分别采用Western Ontario McMaster Universities Arthritis index(WOMAC)和Visual Analog Scale(VAS)作为疗效评分标准,观察2组治疗前后的膝关节临床变化。结果共纳入368例患者,13例失随访,其余完成12周治疗,A组和B组分别优于治疗前(P<0.05);4周时A组较用药前无明显变化(P>0.05),B组明显优于用药前(P<0.05),B组结果优于A组(P<0.05);12周后A、B结果相近,差异无统计学意义(P>0.05)。结论应用硫酸氨基葡萄糖联合和NSAIDs治疗膝骨性关节炎有很好的疗效,长期使用硫酸氨基葡萄糖可以减少对于NSAIDs的依赖可以延缓疾病的进展,减轻NSAIDs使用的不良反应和提高患者的生活质量。
作者 王华 王宪英
出处 《河北医药》 CAS 2014年第8期1159-1161,共3页 Hebei Medical Journal
  • 相关文献

参考文献7

  • 1Ruane R, Griffiths P. Glucosamine therapy compared to ibuprofen for joint pain. Br J Community Nurs,2002,7:148-152.
  • 2Altman R, Asch E, Bloeh D, et al. Development of criteria for the classifi- cation and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum, 1986,29 : 1039 -1049.
  • 3Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis, 1957,16:494-502.
  • 4邱贵兴,翁习生,张克,周乙雄,娄思权,王以朋,李为,张洪,刘岩.盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究[J].中华医学杂志,2005,85(43):3067-3070. 被引量:93
  • 5Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee : network meta-a- nalysis. BMJ ,2010,341 : c4675.
  • 6Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis : part III: Changes in evidence followingsystematic cumulative update of research published through Jan- uary 2009. Osteoarthritis Cartilage,2010,18:476-499.
  • 7Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung, 2001,51 : 699- 725.

二级参考文献16

  • 1徐苓,Michael C Nevitt,Yuqing Zhang,余卫,Piran Alibadi,David T Felson.北京城区老年人膝、髋和手骨关节炎的患病率及其与美国白人患病率的比较研究[J].中华医学杂志,2003,83(14):1206-1209. 被引量:62
  • 2Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg, 2001, 9:71-78.
  • 3Gaby AR. Natural treatments for osteoarthritis. Altern Med Rev, 1999, 4: 330-341.
  • 4Oegema TR Jr, Deloria LB, Sandy JD, et al. Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum, 2002, 46: 2495-2503.
  • 5Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage, 1998, 6:427-434.
  • 6Fenton JI, Chlebek-Brown KA, Peters TL, et al. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis cartilage, 2000, 8: 258-265.
  • 7Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum, 1986, 29: 1039-1049.
  • 8Lequesne MG, Samson M. Indices of severity in osteoarthritis for weight bearing joints. J Rheumatol , 1999, 27 Suppl: 16-18.
  • 9Noack W, Fischer M, Forster KK, et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage, 1994, 2:51-59.
  • 10Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee Osteoarthritis. Arzneimittelforschung, 1998, 48:469-474.

共引文献92

同被引文献100

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部